FDA approves a Takeda Pharmaceuticals supplemental NDA to expand Gattexs (teduglutide) for injection to pediatric patients aged one year and older wit...
The Justice Department says Carefusion is paying $3.3 million to resolve False Claims Act charges that it bought and sold uncleared and unapproved med...
Researchers suggest priorities needed to increase the use of patient-reported outcomes as data in real-world evidence.
FDA approves an EMD Serono and Pfizer NDA for Bavencio (avelumab) in combination with Pfizers Inlyta (axitinib) for the first-line treatment of patien...
FDA approves a Pfizer sNDA for Fragmin (dalteparin sodium) subcutaneous injection to reduce the recurrence of symptomatic venous thromboembolism in pe...
Ethicon recalls its Endo-Surgery Curved Intraluminal Stapler with Adjustable Height Staples and Endo-Surgery Endoscopic Curved Intraluminal Stapler wi...
Iqvia Institute identifies and analyzes trends in drug research and development in the next five years.
University of Florida and Office of Generic Drugs researchers are developing a bioinformatics approach to evaluating bioinequivalence reports on gener...